
Anthony Ricks
Dr. Antony Rix — CEO and co-founder of Lucida Medical, an AI-powered prostate cancer diagnostics platform
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
Jul 22, 2026
How AI is rewriting the rules of cancer diagnosis with Lucida Medical's Antony Rix
4:20
4:30
4:43
4:56
G
4:13GlennHOST
Deferring to your considerable expertise and experience here, can you tell us a bit more about the problems with cancer diagnosis?

Anthony RicksGUEST
What do we need to do better? So actually, we focused on prostate cancer first because it's one of the most common and difficult cancers to diagnose.

Anthony RicksGUEST
In the past, we used to screen for prostate cancer using the PSA blood test and a thing called the digital rectal examination, which I won't I don't need to go into more detail about it.

Anthony RicksGUEST
The result was that men with even the lowest grade group one prostate cancer ended up being over-treated in very large numbers by removing or irradiating the gland.

Anthony RicksGUEST
Now, it's actually since been shown that that grade group 1 low grade prostate cancer doesn't metastasize.
G
7:24GlennHOST
So how does your AI solve these problems in technical terms? What data inputs does it need and where can it be used in the diagnostic pathway?